(Q72778544)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6219577%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

title

Effects of dichloromethylene diphosphonate in women with breast carcinoma metastatic to the skeleton (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6219577%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

1 reference

E. S. Siris

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6219577

31 August 2023

G. A. Hyman

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6219577

31 August 2023

R. E. Canfield

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6219577

31 August 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6219577

31 August 2023

publication date

1 March 1983

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6219577%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

29 October 2019

https://api.elsevier.com/content/article/PII:0002934383909580?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90958-0

https://api.elsevier.com/content/article/PII:0002934383909580?httpAccept=text/plain

31 August 2023

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90958-0

American Journal of Medicine

31 August 2023

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6219577%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

volume

74

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6219577%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6219577%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

page(s)

401-406

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6219577%20AND%20SRC:MED&resulttype=core&format=json

The inhibition of calcium hydroxypatite crystal growth by polyphosphonates and polyphosphates

29 October 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90958-0

The influence of pyrophosphate, condensed phosphates, phosphonates and other phosphate compounds on the dissolution of hydroxyapatite in vitro and on bone resorption induced by parathyroid hormone in tissue culture and in thyroparathyroidectomised r

31 August 2023

2

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90958-0

Effect of ethane-1-hydroxy-1,1-diphosphonate (EHDP) and dichloromethylene diphosphonate (Cl 2 MDP) on the calcification and resorption of cartilage and bone in the tibial epiphysis and metaphysis of rats

31 August 2023

3

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90958-0

The comparative effects of dichloromethylene diphosphonate (Cl2MDP) and ethane-1-hydroxy-1,1-diphosphonate (EHDP) on growth and modeling of the rat tibia

31 August 2023

4

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90958-0

Experimental basis for the clinical use of diphosphonates in paget's disease of bone

31 August 2023

5

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90958-0

Diphosphonates and Page's disease of bone.

31 August 2023

6

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90958-0

Influence of disodium etidronate on clinical and laboratory manifestations of Paget's disease of bone (osteitis deformans)

31 August 2023

7

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90958-0

Diphosphonate Therapy of Paget's Disease of Bone

31 August 2023

8

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90958-0

Effects of dichloromethylene diphosphonate on serum and urinary calcium in primary hyperparathyroidism

31 August 2023

9

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90958-0

Effect of dichloromethylene diphosphonate in Paget's disease of bone and in hypercalcaemia due to primary hyperparathyroidism or malignant disease

31 August 2023

10

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90958-0

Effects of disodium dichloromethylene diphosphonate on Paget's disease of bone

31 August 2023

11

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90958-0

Treatment of Paget's disease with (3-amino-1-hydroxypropylidene)-1, 1-bisphosphonate (A.P.D.)

31 August 2023

12

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90958-0

Effects of dichloromethylene diphosphonate on skeletal mobilization of calcium in multiple myeloma

31 August 2023

13

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90958-0

Effects of disodium dichloromethylene diphosphonate on hypercalcemia produced by bone metastases

31 August 2023

14

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90958-0

Inhibition of osteolytic bone lesions by (3-amino-1-hydroxypropylidene)-1, 1-bisphosphonate (A.P.D.)

31 August 2023

15

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90958-0

Hypercalcemia of malignancy: treatment with intravenous dichloromethylene diphosphonate

31 August 2023

16

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90958-0

Parenteral diphosphonates for treating malignant hypercalcemia

31 August 2023

18

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90958-0

Comparison of two parenteral diphosphonates in hypercalcemia of malignancy

31 August 2023

19

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90958-0

Therapy of hypercalcemia due to parathyroid carcinoma with intravenous dichloromethylene diphosphonate

31 August 2023

20

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90958-0

The hypercalciurias. Causes, parathyroid functions, and diagnostic criteria

31 August 2023

21

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90958-0

Modifications of a specific assay for hydroxyproline in urine

31 August 2023

22

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90958-0

Direct resorption of bone by human breast cancer cells in vitro

31 August 2023

23

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90958-0

Evidence for the secretion of an osteoclast stimulating factor in myeloma.

31 August 2023

24

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90958-0

Mechanisms of bone destruction in the development of skeletal metastases

31 August 2023

26

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90958-0

Biochemical evaluation of patients with cancer-associated hypercalcemia: evidence for humoral and nonhumoral groups.

31 August 2023

27

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90958-0

31 August 2023

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6219577%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

1 reference